TY - JOUR AU - Black, D. PY - 1998 DA - 1998// TI - The limitations of evidence JO - J R Coll Physicians Lond VL - 32 ID - Black1998 ER - TY - JOUR AU - Feinstein, A. R. AU - Horwitz, R. I. PY - 1997 DA - 1997// TI - Problems in the "evidence" of "evidence-based medicine" JO - Am J Med VL - 103 UR - https://doi.org/10.1016/S0002-9343(97)00244-1 DO - 10.1016/S0002-9343(97)00244-1 ID - Feinstein1997 ER - TY - JOUR AU - Caplan, L. R. PY - 2001 DA - 2001// TI - Evidence based medicine: concerns of a clinical neurologist JO - J Neurol Neurosurg Psychiatry VL - 71 UR - https://doi.org/10.1136/jnnp.71.5.569 DO - 10.1136/jnnp.71.5.569 ID - Caplan2001 ER - TY - JOUR AU - Rothwell, P. M. PY - 1995 DA - 1995// TI - Can overall results of clinical trials be applied to all patients? JO - Lancet VL - 345 UR - https://doi.org/10.1016/S0140-6736(95)90120-5 DO - 10.1016/S0140-6736(95)90120-5 ID - Rothwell1995 ER - TY - JOUR AU - Rothwell, P. M. AU - Mehta, Z. AU - Howard, S. C. AU - Gutnikov, S. A. AU - Warlow, C. P. PY - 2005 DA - 2005// TI - Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)70156-2 DO - 10.1016/S0140-6736(05)70156-2 ID - Rothwell2005 ER - TY - JOUR AU - Kent, D. M. AU - Hayward, R. A. PY - 2007 DA - 2007// TI - Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.10.1209 DO - 10.1001/jama.298.10.1209 ID - Kent2007 ER - TY - JOUR AU - Kravitz, R. L. AU - Duan, N. AU - Braslow, J. PY - 2004 DA - 2004// TI - Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages JO - Milbank Q VL - 82 UR - https://doi.org/10.1111/j.0887-378X.2004.00327.x DO - 10.1111/j.0887-378X.2004.00327.x ID - Kravitz2004 ER - TY - JOUR AU - Kent, D. M. AU - Alsheikh-Ali, A. A. AU - Hayward, R. A. PY - 2008 DA - 2008// TI - Competing risk and heterogeneity of treatment effect in clinical trials JO - Trials VL - 9 UR - https://doi.org/10.1186/1745-6215-9-30 DO - 10.1186/1745-6215-9-30 ID - Kent2008 ER - TY - JOUR AU - Hayward, R. A. AU - Kent, D. M. AU - Vijan, S. AU - Hofer, T. P. PY - 2006 DA - 2006// TI - Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis JO - BMC Med Res Methodol VL - 6 UR - https://doi.org/10.1186/1471-2288-6-18 DO - 10.1186/1471-2288-6-18 ID - Hayward2006 ER - TY - JOUR AU - Ebrahim, S. AU - Smith, G. D. PY - 1999 DA - 1999// TI - The 'number need to treat': does it help clinical decision making? JO - J Hum Hypertens VL - 13 UR - https://doi.org/10.1038/sj.jhh.1000919 DO - 10.1038/sj.jhh.1000919 ID - Ebrahim1999 ER - TY - JOUR AU - Furukawa, T. A. AU - Guyatt, G. H. AU - Griffith, L. E. PY - 2002 DA - 2002// TI - Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses JO - Int J Epidemiol VL - 31 UR - https://doi.org/10.1093/ije/31.1.72 DO - 10.1093/ije/31.1.72 ID - Furukawa2002 ER - TY - JOUR AU - Ioannidis, J. P. AU - Lau, J. PY - 1997 DA - 1997// TI - The impact of high-risk patients on the results of clinical trials JO - J Clin Epidemiol VL - 50 UR - https://doi.org/10.1016/S0895-4356(97)00149-2 DO - 10.1016/S0895-4356(97)00149-2 ID - Ioannidis1997 ER - TY - JOUR AU - Glasziou, P. P. AU - Irwig, L. M. PY - 1995 DA - 1995// TI - An evidence based approach to individualising treatment JO - BMJ VL - 311 UR - https://doi.org/10.1136/bmj.311.7016.1356 DO - 10.1136/bmj.311.7016.1356 ID - Glasziou1995 ER - TY - JOUR AU - Hayward, R. A. AU - Kent, D. M. AU - Vijan, S. AU - Hofer, T. P. PY - 2005 DA - 2005// TI - Reporting clinical trial results to inform providers, payers, and consumers JO - Health Aff (Millwood) VL - 24 UR - https://doi.org/10.1377/hlthaff.24.6.1571 DO - 10.1377/hlthaff.24.6.1571 ID - Hayward2005 ER - TY - JOUR AU - Kent, D. M. AU - Ruthazer, R. AU - Selker, H. P. PY - 2003 DA - 2003// TI - Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? JO - Stroke VL - 34 UR - https://doi.org/10.1161/01.STR.0000051506.43212.8B DO - 10.1161/01.STR.0000051506.43212.8B ID - Kent2003 ER - TY - JOUR AU - Ioannidis, J. P. AU - Lau, J. PY - 1998 DA - 1998// TI - Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm JO - Am J Epidemiol VL - 148 UR - https://doi.org/10.1093/oxfordjournals.aje.a009590 DO - 10.1093/oxfordjournals.aje.a009590 ID - Ioannidis1998 ER - TY - JOUR AU - Kent, D. M. AU - Hayward, R. A. AU - Griffith, J. L. AU - Vijan, S. AU - Beshansky, J. R. AU - Califf, R. M. AU - Selker, H. P. PY - 2002 DA - 2002// TI - An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase JO - Am J Med VL - 113 UR - https://doi.org/10.1016/S0002-9343(02)01160-9 DO - 10.1016/S0002-9343(02)01160-9 ID - Kent2002 ER - TY - JOUR AU - Kent, D. M. AU - Ruthazer, R. AU - Griffith, J. L. AU - Beshansky, J. R. AU - Grines, C. L. AU - Aversano, T. AU - Concannon, T. W. AU - Zalenski, R. J. AU - Selker, H. P. PY - 2007 DA - 2007// TI - Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction JO - Am J Cardiol VL - 99 UR - https://doi.org/10.1016/j.amjcard.2006.12.068 DO - 10.1016/j.amjcard.2006.12.068 ID - Kent2007 ER - TY - JOUR AU - Kent, D. M. AU - Jafar, T. H. AU - Hayward, R. A. AU - Tighiouart, H. AU - Landa, M. AU - de Jong, P. AU - de Zeeuw, D. AU - Remuzzi, G. AU - Kamper, A. L. AU - Levey, A. S. PY - 2007 DA - 2007// TI - Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease JO - J Am Soc Nephrol VL - 18 UR - https://doi.org/10.1681/ASN.2006101081 DO - 10.1681/ASN.2006101081 ID - Kent2007 ER - TY - JOUR AU - Trikalinos, T. A. AU - Ioannidis, J. P. PY - 2001 DA - 2001// TI - Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data JO - J Clin Epidemiol VL - 54 UR - https://doi.org/10.1016/S0895-4356(00)00311-5 DO - 10.1016/S0895-4356(00)00311-5 ID - Trikalinos2001 ER - TY - JOUR AU - Rothwell, P. M. AU - Warlow, C. P. PY - 1999 DA - 1999// TI - Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)11415-0 DO - 10.1016/S0140-6736(98)11415-0 ID - Rothwell1999 ER - TY - JOUR AU - Brookes, S. T. AU - Whitley, E. AU - Peters, T. J. AU - Mulheran, P. A. AU - Egger, M. AU - Davey, S. G. PY - 2001 DA - 2001// TI - Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives JO - Health Technol Assess VL - 5 UR - https://doi.org/10.3310/hta5330 DO - 10.3310/hta5330 ID - Brookes2001 ER - TY - JOUR AU - Brookes, S. T. AU - Whitely, E. AU - Egger, M. AU - Smith, G. D. AU - Mulheran, P. A. AU - Peters, T. J. PY - 2004 DA - 2004// TI - Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test JO - J Clin Epidemiol VL - 57 UR - https://doi.org/10.1016/j.jclinepi.2003.08.009 DO - 10.1016/j.jclinepi.2003.08.009 ID - Brookes2004 ER - TY - JOUR AU - Albert, J. M. AU - Gadbury, G. L. AU - Mascha, E. J. PY - 2005 DA - 2005// TI - Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes JO - Biom J VL - 47 UR - https://doi.org/10.1002/bimj.200510157 DO - 10.1002/bimj.200510157 ID - Albert2005 ER - TY - JOUR AU - Furberg, C. D. AU - Byington, R. P. PY - 1983 DA - 1983// TI - What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience JO - Circulation VL - 67 ID - Furberg1983 ER - TY - JOUR AU - Tannock, I. F. PY - 1996 DA - 1996// TI - False-positive results in clinical trials: multiple significance tests and the problem of unreported comparisons JO - J Natl Cancer Inst VL - 88 UR - https://doi.org/10.1093/jnci/88.3-4.206 DO - 10.1093/jnci/88.3-4.206 ID - Tannock1996 ER - TY - JOUR AU - Rothwell, P. M. PY - 2005 DA - 2005// TI - Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)17709-5 DO - 10.1016/S0140-6736(05)17709-5 ID - Rothwell2005 ER - TY - JOUR AU - Assmann, S. F. AU - Pocock, S. J. AU - Enos, L. E. AU - Kasten, L. E. PY - 2000 DA - 2000// TI - Subgroup analysis and other (mis)uses of baseline data in clinical trials JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02039-0 DO - 10.1016/S0140-6736(00)02039-0 ID - Assmann2000 ER - TY - JOUR AU - Oxman, A. D. AU - Guyatt, G. H. PY - 1992 DA - 1992// TI - A consumer's guide to subgroup analyses JO - Ann Intern Med VL - 116 UR - https://doi.org/10.7326/0003-4819-116-1-78 DO - 10.7326/0003-4819-116-1-78 ID - Oxman1992 ER - TY - JOUR AU - Hernandez, A. V. AU - Boersma, E. AU - Murray, G. D. AU - Habbema, J. D. AU - Steyerberg, E. W. PY - 2006 DA - 2006// TI - Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading? JO - Am Heart J VL - 151 UR - https://doi.org/10.1016/j.ahj.2005.04.020 DO - 10.1016/j.ahj.2005.04.020 ID - Hernandez2006 ER - TY - JOUR AU - Ioannidis, J. P. PY - 2005 DA - 2005// TI - Why most published research findings are false JO - PLoS Med VL - 2 UR - https://doi.org/10.1371/journal.pmed.0020124 DO - 10.1371/journal.pmed.0020124 ID - Ioannidis2005 ER - TY - JOUR AU - Feiveson, A. H. PY - 2009 DA - 2009// TI - Power by simulation JO - The Stata Journal VL - 2 ID - Feiveson2009 ER - TY - JOUR AU - Wang, R. AU - Lagakos, S. W. AU - Ware, J. H. AU - Hunter, D. J. AU - Drazen, J. M. PY - 2007 DA - 2007// TI - Statistics in medicine--reporting of subgroup analyses in clinical trials JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMsr077003 DO - 10.1056/NEJMsr077003 ID - Wang2007 ER - TY - JOUR AU - Yusuf, S. AU - Wittes, J. AU - Probstfield, J. AU - Tyroler, H. A. PY - 1991 DA - 1991// TI - Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JO - JAMA VL - 266 UR - https://doi.org/10.1001/jama.1991.03470010097038 DO - 10.1001/jama.1991.03470010097038 ID - Yusuf1991 ER - TY - JOUR AU - Parker, A. B. AU - Naylor, C. D. PY - 2000 DA - 2000// TI - Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials JO - Am Heart J VL - 139 UR - https://doi.org/10.1067/mhj.2000.106610 DO - 10.1067/mhj.2000.106610 ID - Parker2000 ER - TY - JOUR AU - Pocock, S. J. AU - Assmann, S. E. AU - Enos, L. E. AU - Kasten, L. E. PY - 2002 DA - 2002// TI - Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1296 DO - 10.1002/sim.1296 ID - Pocock2002 ER - TY - JOUR AU - Kraemer, H. C. AU - Frank, E. AU - Kupfer, D. J. PY - 2006 DA - 2006// TI - Moderators of treatment outcomes: clinical, research, and policy importance JO - JAMA VL - 296 UR - https://doi.org/10.1001/jama.296.10.1286 DO - 10.1001/jama.296.10.1286 ID - Kraemer2006 ER - TY - JOUR AU - Davidoff, F. PY - 2009 DA - 2009// TI - Heterogeneity is not always noise: lessons from improvement JO - JAMA VL - 302 UR - https://doi.org/10.1001/jama.2009.1845 DO - 10.1001/jama.2009.1845 ID - Davidoff2009 ER - TY - JOUR AU - Gabler, N. B. AU - Duan, N. AU - Liao, D. AU - Elmore, J. G. AU - Ganiats, T. G. AU - Kravitz, R. L. PY - 2009 DA - 2009// TI - Dealing with heterogeneity of treatment effects: is the literature up to the challenge? JO - Trials VL - 10 UR - https://doi.org/10.1186/1745-6215-10-43 DO - 10.1186/1745-6215-10-43 ID - Gabler2009 ER - TY - JOUR AU - Sun, X. AU - Briel, M. AU - Walter, S. D. AU - Guyatt, G. H. PY - 2010 DA - 2010// TI - Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c117 DO - 10.1136/bmj.c117 ID - Sun2010 ER - TY - JOUR AU - Greenfield, S. AU - Kravitz, R. AU - Duan, N. AU - Kaplan, S. H. PY - 2007 DA - 2007// TI - Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment JO - Am J Med VL - 120 UR - https://doi.org/10.1016/j.amjmed.2007.02.002 DO - 10.1016/j.amjmed.2007.02.002 ID - Greenfield2007 ER - TY - JOUR AU - Proschan, M. A. AU - Waclawiw, M. A. PY - 2000 DA - 2000// TI - Practical guidelines for multiplicity adjustment in clinical trials JO - Control Clin Trials VL - 21 UR - https://doi.org/10.1016/S0197-2456(00)00106-9 DO - 10.1016/S0197-2456(00)00106-9 ID - Proschan2000 ER - TY - JOUR AU - Bender, R. AU - Lange, S. PY - 2001 DA - 2001// TI - Adjusting for multiple testing--when and how? JO - J Clin Epidemiol VL - 54 UR - https://doi.org/10.1016/S0895-4356(00)00314-0 DO - 10.1016/S0895-4356(00)00314-0 ID - Bender2001 ER - TY - JOUR AU - Tzoulaki, I. AU - Liberopoulos, G. AU - Ioannidis, J. P. PY - 2009 DA - 2009// TI - Assessment of claims of improved prediction beyond the Framingham risk score JO - JAMA VL - 302 UR - https://doi.org/10.1001/jama.2009.1757 DO - 10.1001/jama.2009.1757 ID - Tzoulaki2009 ER - TY - JOUR AU - Ioannidis, J. P. AU - Tzoulaki, I. PY - 2010 DA - 2010// TI - What makes a good predictor?: the evidence applied to coronary artery calcium score JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.503 DO - 10.1001/jama.2010.503 ID - Ioannidis2010 ER - TY - JOUR AU - Antman, E. M. AU - Cohen, M. AU - Bernink, P. J. AU - McCabe, C. H. AU - Horacek, T. AU - Papuchis, G. AU - Mautner, B. AU - Corbalan, R. AU - Radley, D. AU - Braunwald, E. PY - 2000 DA - 2000// TI - The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JO - JAMA VL - 284 UR - https://doi.org/10.1001/jama.284.7.835 DO - 10.1001/jama.284.7.835 ID - Antman2000 ER - TY - JOUR AU - Morrow, D. A. AU - Antman, E. M. AU - Snapinn, S. M. AU - McCabe, C. H. AU - Theroux, P. AU - Braunwald, E. PY - 2002 DA - 2002// TI - An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS JO - Eur Heart J VL - 23 UR - https://doi.org/10.1053/euhj.2001.2738 DO - 10.1053/euhj.2001.2738 ID - Morrow2002 ER - TY - JOUR AU - Cannon, C. P. AU - Weintraub, W. S. AU - Demopoulos, L. A. AU - Vicari, R. AU - Frey, M. J. AU - Lakkis, N. AU - Neumann, F. J. AU - Robertson, D. H. AU - DeLucca, P. T. AU - DiBattiste, P. M. AU - Gibson, C. M. AU - Braunwald, E. PY - 2001 DA - 2001// TI - Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200106213442501 DO - 10.1056/NEJM200106213442501 ID - Cannon2001 ER - TY - JOUR AU - Gage, B. F. AU - Waterman, A. D. AU - Shannon, W. AU - Boechler, M. AU - Rich, M. W. AU - Radford, M. J. PY - 2001 DA - 2001// TI - Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.22.2864 DO - 10.1001/jama.285.22.2864 ID - Gage2001 ER - TY - JOUR AU - Gage, B. F. AU - van Walraven, C. AU - Pearce, L. AU - Hart, R. G. AU - Koudstaal, P. J. AU - Boode, B. S. AU - Petersen, P. PY - 2004 DA - 2004// TI - Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000145172.55640.93 DO - 10.1161/01.CIR.0000145172.55640.93 ID - Gage2004 ER - TY - JOUR AU - Pocock, S. J. AU - Lubsen, J. PY - 2008 DA - 2008// TI - More on subgroup analyses in clinical trials JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMc0800616 DO - 10.1056/NEJMc0800616 ID - Pocock2008 ER - TY - JOUR AU - Follmann, D. A. AU - Proschan, M. A. PY - 1999 DA - 1999// TI - A multivariate test of interaction for use in clinical trials JO - Biometrics VL - 55 UR - https://doi.org/10.1111/j.0006-341X.1999.01151.x DO - 10.1111/j.0006-341X.1999.01151.x ID - Follmann1999 ER - TY - JOUR AU - Chen, Z. M. AU - Jiang, L. X. AU - Chen, Y. P. AU - Xie, J. X. AU - Pan, H. C. AU - Peto, R. AU - Collins, R. AU - Liu, L. S. PY - 2005 DA - 2005// TI - Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67660-X DO - 10.1016/S0140-6736(05)67660-X ID - Chen2005 ER - TY - JOUR AU - Yusuf, S. AU - Diener, H. C. AU - Sacco, R. L. AU - Cotton, D. AU - Ounpuu, S. AU - Lawton, W. A. AU - Palesch, Y. AU - Martin, R. H. AU - Albers, G. W. AU - Bath, P. AU - Bornstein, N. AU - Chan, B. P. AU - Chen, S. T. AU - Cunha, L. AU - Dahlöf, B. AU - De Keyser, J. AU - Donnan, G. A. AU - Estol, C. AU - Gorelick, P. AU - Gu, V. AU - Hermansson, K. AU - Hilbrich, L. AU - Kaste, M. AU - Lu, C. AU - Machnig, T. AU - Pais, P. AU - Roberts, R. AU - Skvortsova, V. AU - Teal, P. AU - Toni, D. AU - VanderMaelen, C. AU - Voigt, T. AU - Weber, M. AU - Yoon, B. W. PY - 2008 DA - 2008// TI - Telmisartan to prevent recurrent stroke and cardiovascular events JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0804593 DO - 10.1056/NEJMoa0804593 ID - Yusuf2008 ER - TY - JOUR AU - Califf, R. M. AU - Woodlief, L. H. AU - Harrell, F. E. AU - Lee, K. L. AU - White, H. D. AU - Guerci, A. AU - Barbash, G. I. AU - Simes, R. J. AU - Weaver, W. D. AU - Simoons, M. L. AU - Topol, E. J. PY - 1997 DA - 1997// TI - Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators JO - Am Heart J VL - 133 UR - https://doi.org/10.1016/S0002-8703(97)70164-9 DO - 10.1016/S0002-8703(97)70164-9 ID - Califf1997 ER - TY - JOUR AU - Litwin, M. S. AU - Greenfield, S. AU - Elkin, E. P. AU - Lubeck, D. P. AU - Broering, J. M. AU - Kaplan, S. H. PY - 2007 DA - 2007// TI - Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22615 DO - 10.1002/cncr.22615 ID - Litwin2007 ER - TY - JOUR AU - Braithwaite, R. S. AU - Concato, J. AU - Chang, C. C. AU - Roberts, M. S. AU - Justice, A. C. PY - 2007 DA - 2007// TI - A framework for tailoring clinical guidelines to comorbidity at the point of care JO - Arch Intern Med VL - 167 UR - https://doi.org/10.1001/archinte.167.21.2361 DO - 10.1001/archinte.167.21.2361 ID - Braithwaite2007 ER - TY - JOUR AU - Greenfield, S. AU - Billimek, J. AU - Pellegrini, F. AU - Franciosi, M. AU - De Berardis, G. AU - Nicolucci, A. AU - Kaplan, S. H. PY - 2009 DA - 2009// TI - Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study JO - Ann Intern Med VL - 151 UR - https://doi.org/10.7326/0003-4819-151-12-200912150-00005 DO - 10.7326/0003-4819-151-12-200912150-00005 ID - Greenfield2009 ER - TY - JOUR AU - Gurwitz, J. H. AU - Gore, J. M. AU - Goldberg, R. J. AU - Barron, H. V. AU - Breen, T. AU - Rundle, A. C. AU - Sloan, M. A. AU - French, W. AU - Rogers, W. J. PY - 1998 DA - 1998// TI - Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2 JO - Ann Intern Med VL - 129 UR - https://doi.org/10.7326/0003-4819-129-8-199810150-00002 DO - 10.7326/0003-4819-129-8-199810150-00002 ID - Gurwitz1998 ER - TY - JOUR AU - Shireman, T. I. AU - Mahnken, J. D. AU - Howard, P. A. AU - Kresowik, T. F. AU - Hou, Q. AU - Ellerbeck, E. F. PY - 2006 DA - 2006// TI - Development of a contemporary bleeding risk model for elderly warfarin recipients JO - Chest VL - 130 UR - https://doi.org/10.1378/chest.130.5.1390 DO - 10.1378/chest.130.5.1390 ID - Shireman2006 ER - TY - JOUR AU - Charlson, M. AU - Szatrowski, T. P. AU - Peterson, J. AU - Gold, J. PY - 1994 DA - 1994// TI - Validation of a combined comorbidity index JO - J Clin Epidemiol VL - 47 UR - https://doi.org/10.1016/0895-4356(94)90129-5 DO - 10.1016/0895-4356(94)90129-5 ID - Charlson1994 ER - TY - JOUR AU - Vijan, S. AU - Kent, D. M. AU - Hayward, R. A. PY - 2000 DA - 2000// TI - Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus? JO - Diabetologia VL - 43 UR - https://doi.org/10.1007/s001250050017 DO - 10.1007/s001250050017 ID - Vijan2000 ER - TY - JOUR AU - Nallamothu, B. K. AU - Hayward, R. A. AU - Bates, E. R. PY - 2008 DA - 2008// TI - Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies JO - Circulation VL - 118 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.703579 DO - 10.1161/CIRCULATIONAHA.107.703579 ID - Nallamothu2008 ER - TY - JOUR AU - Yusuf, S. AU - Zucker, D. AU - Peduzzi, P. AU - Fisher, L. D. AU - Takaro, T. AU - Kennedy, J. W. AU - Davis, K. AU - Killip, T. AU - Passamani, E. AU - Norris, R. PY - 1994 DA - 1994// TI - Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)91963-1 DO - 10.1016/S0140-6736(94)91963-1 ID - Yusuf1994 ER - TY - STD TI - West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996, 348: 1339-1342. 10.1016/S0140-6736(96)04292-4. ID - ref65 ER - TY - JOUR AU - Mehta, S. R. AU - Granger, C. B. AU - Boden, W. E. AU - Steg, P. G. AU - Bassand, J. P. AU - Faxon, D. P. AU - Afzal, R. AU - Chrolavicius, S. AU - Jolly, S. S. AU - Widimsky, P. AU - Avezum, A. AU - Rupprecht, H. J. AU - Zhu, J. AU - Col, J. AU - Natarajan, M. K. AU - Horsman, C. AU - Fox, K. A. AU - Yusuf, S. PY - 2009 DA - 2009// TI - Early versus delayed invasive intervention in acute coronary syndromes JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0807986 DO - 10.1056/NEJMoa0807986 ID - Mehta2009 ER - TY - JOUR AU - Mehta, S. R. AU - Cannon, C. P. AU - Fox, K. A. AU - Wallentin, L. AU - Boden, W. E. AU - Spacek, R. AU - Widimsky, P. AU - McCullough, P. A. AU - Hunt, D. AU - Braunwald, E. AU - Yusuf, S. PY - 2005 DA - 2005// TI - Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JO - JAMA VL - 293 UR - https://doi.org/10.1001/jama.293.23.2908 DO - 10.1001/jama.293.23.2908 ID - Mehta2005 ER - TY - JOUR AU - Hillis, L. D. AU - Lange, R. A. PY - 2009 DA - 2009// TI - Optimal management of acute coronary syndromes JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMe0902632 DO - 10.1056/NEJMe0902632 ID - Hillis2009 ER - TY - JOUR AU - Kent, D. M. AU - Ruthazer, R. AU - Griffith, J. L. AU - Beshansky, J. R. AU - Concannon, T. W. AU - Aversano, T. AU - Grines, C. L. AU - Zalenski, R. J. AU - Selker, H. P. PY - 2008 DA - 2008// TI - A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction JO - Am J Cardiol VL - 101 UR - https://doi.org/10.1016/j.amjcard.2007.10.050 DO - 10.1016/j.amjcard.2007.10.050 ID - Kent2008 ER - TY - JOUR AU - Thune, J. J. AU - Hoefsten, D. E. AU - Lindholm, M. G. AU - Mortensen, L. S. AU - Andersen, H. R. AU - Nielsen, T. T. AU - Kober, L. AU - Kelbaek, H. PY - 2005 DA - 2005// TI - Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.558676 DO - 10.1161/CIRCULATIONAHA.105.558676 ID - Thune2005 ER - TY - STD TI - Xigris: drotrecogin alfa (activated): PV 3420. AMP. 2001, Indianapolis, IN, Eli Lilly & co ID - ref71 ER - TY - JOUR AU - Abraham, E. AU - Laterre, P. F. AU - Garg, R. AU - Levy, H. AU - Talwar, D. AU - Trzaskoma, B. L. AU - François, B. AU - Guy, J. S. AU - Brückmann, M. AU - Rea-Neto, A. AU - Rossaint, R. AU - Perrotin, D. AU - Sablotzki, A. AU - Arkins, N. AU - Utterback, B. G. AU - Macias, W. L. PY - 2005 DA - 2005// TI - Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050935 DO - 10.1056/NEJMoa050935 ID - Abraham2005 ER -